Cooley LLP and Matheson LLP advised Horizon, while Sullivan & Cromwell LLP and William Fry LLP advised Amgen. Debevoise & Plimpton LLP advised JP Morgan. Macfarlanes...
Amgen’s Acquisition of Horizon Therapeutics
Avant’s $250 Million Financing from Ares
Cooley advised Avant on the deal. Avant, a credit-first financial technology company, announced that it secured $250 million of corporate debt and redeemable preferred equity from...
Drata’s $200 Million Series C Funding Round
Cooley advised Drata on the deal. Drata, a continuous security and compliance automation platform, announced its $200 million Series C funding round. The latest round of funding,...
AstraZeneca’s Acquisition of Neogene Therapeutics
Cooley advised Neogene Therapeutics on the deal. Neogene Therapeutics, a global clinical-stage biotechnology company, signed its definitive agreement to be acquired by AstraZeneca for a total consideration...
Sixth Street Growth’s Investment in Atlas
Sidley represented Sixth Street Growth on the deal while Cooley advised Atlas. Sixth Street Growth announced its Series B strategic investment of up to US$200 million in...
Poseida Therapeutics’ Collaboration and License Agreement With Roche
Cooley advised Poseida Therapeutics on the deal. Poseida Therapeutics, a clinical-stage biopharmaceutical company, announced its strategic collaboration and license agreement with Roche. The agreement will leverage Poseida’s...
Contentsquare’s $600 Million Fundraising
Peltier Juvigny Marpeau & Associés and Cooley advised Contentsquare on the transaction. Cleary Gottlieb advised Sixth Street; Jones Day advised Bpifrance and Eurazeo; Ashurst advised BlackRock;...
Vendr’s $150 Million Series B Funding Round
Cooley LLP advised Vendr on the deal. Vendr, a software as a service buying platform, announced its $150 million Series B funding round, bringing the company...
Chainalysis’ $170 Million Series F Financing Round
Cooley advised Chainalysis on the deal. Chainalysis, a blockchain data platform, announced its $170 million Series F preferred stock financing round, bringing its valuation to $8.6...
Kriya Therapeutics’ $270 Million Series C Financing Round
Cooley advised Kriya Therapeutics on the deal. Kriya Therapeutics, a fully integrated gene therapy company pioneering novel technologies and therapeutics, announced its $270 Million Series C financing...
Grindr’s Merger with Tiga Acquisition Corp.
Cooley advised Grindr on the deal while Milbank LLP represented Tiga Acquisition Corp. Grindr, the #1 social network for the LGBTQ+ community, announced its definitive agreement to...
Abnormal Security’s $210 Million Series C Financing Round
Cooley advised Abnormal Security on the deal. Abnormal Security, a leading artificial intelligence-based cloud-native email security platform, announced its $210 million Series C financing round, which...